Porokeratosis Plantaris, Palmaris et Disseminata
Rare genetic skin disorder starting on palms and soles, spreading body-wide with scaly annular lesions.

Introduction
Porokeratosis represents a group of uncommon disorders characterized by abnormal keratinization of the skin, manifesting as annular lesions with a distinctive raised, hyperkeratotic border known as the cornoid lamella. Among its rare variants,
porokeratosis plantaris, palmaris et disseminata (PPPD)
stands out for its progressive nature, beginning with thick, scaly patches on the palms and soles before disseminating to the extremities and trunk. This condition, also termed porokeratosis palmaris et plantaris disseminata, typically emerges in adolescence, though adult-onset cases occur, and disproportionately affects males. PPPD lesions cause significant discomfort, including pruritus and pain, particularly on weight-bearing plantar surfaces, potentially impairing mobility and quality of life. While the precise pathogenesis involves clonal keratinocyte proliferation with disordered differentiation, its recognition is crucial due to a small risk of malignant transformation to squamous cell carcinoma.Demographics
PPPD predominantly manifests during adolescence, with initial lesions appearing on palms and soles in the teenage years, though sporadic adult-onset has been documented up to the sixth decade. Early reports indicated a male predominance, approximately twice as common in men, though contemporary series suggest less disparity. Familial aggregation underscores its genetic basis, with autosomal dominant inheritance prevalent; sporadic de novo mutations account for isolated cases. Geographically, cases are reported worldwide without strong ethnic bias, though underdiagnosis in non-Caucasian populations may skew data. The condition’s rarity—fewer than 100 well-documented cases—hampers precise epidemiologic profiling, but it represents under 5% of all porokeratoses. Summer exacerbation links to environmental triggers like UV exposure atop genetic susceptibility.
Causes
The etiology of PPPD centers on genetic predisposition, most commonly inherited in an autosomal dominant pattern, with a potential locus on chromosome 12q24.1-q24.2. Sporadic instances likely arise from somatic mutations fostering epidermal keratinocyte clones with dysregulated terminal differentiation. Pathophysiologically, abnormal keratinocyte proliferation underlies the cornoid lamella, a histopathologic hallmark featuring parakeratotic columns atop thinned epidermis, linked to disrupted loricrin expression and premature apoptosis. Environmental cofactors include ultraviolet radiation, which worsens lesions seasonally, and immunosuppression, though less prominent in PPPD than actinic variants. No infectious triggers are confirmed, distinguishing PPPD from porokeratoses associated with HIV or transplant patients. Genetic heterogeneity exists; some kindreds exhibit X-linked traits. Overall, PPPD exemplifies a genodermatosis where heritable keratinocyte instability interacts with external stressors.
Clinical features
PPPD initiates with small, pruritic or painful keratotic papules on the palms and soles, evolving into punctate, hyperkeratotic lesions that coalesce into thick, confluent plaques on pressure sites. Plantar involvement causes disability via foot pain, while palmar lesions are less symptomatic. Lesions disseminate centrifugally, forming numerous superficial, annular papules (1-3 mm) with atrophic, hyperpigmented centers and raised, ridged borders on extremities, trunk, neck, and face; mucosal sparing is typical. Trunk lesions appear reddish-brown, thinned centrally with defined hyperkeratotic rims. Pruritus varies from mild to severe, exacerbated by summer heat. Progression is chronic, fluctuating, with coalescence on palms/soles contrasting discrete body papules. A 66-year-old case illustrated thick plantar plaques alongside facial annular lesions over 20 years.
| Site | Lesion Morphology | Symptoms | Progression |
|---|---|---|---|
| Palms/Soles | Thick, confluent hyperkeratotic plaques; punctate papules | Painful, disabling; pruritic | Early onset, coalescing |
| Extremities/Trunk | Superficial annular papules with raised borders | Mild itch; asymptomatic | Later dissemination |
| Face/Neck | Discrete hyperkeratotic papules | Pruritic | Variable |
Complications
As a chronic, progressive disorder, PPPD impairs quality of life through tender plantar keratoses limiting ambulation and chronic pruritus disrupting sleep. Functional disability from hyperkeratotic soles mimics palmoplantar keratoderma. A critical concern is the risk of cutaneous squamous cell carcinoma (SCC) within longstanding lesions, reported in multiple subtypes including PPPD, necessitating vigilant surveillance. Malignant transformation, though rare (<10%), underscores biopsy of indurated or ulcerated sites. Secondary bacterial infections from excoriations and koebnerization at trauma sites compound morbidity. Psychosocial burden from visible dissemination affects self-esteem, particularly in adolescents. No systemic associations like internal malignancy are established, unlike disseminated superficial actinic porokeratosis.
Diagnosis
Diagnosis hinges on clinical morphology—annular palmoplantar lesions disseminating body-wide—and confirmed by skin biopsy revealing the pathognomonic cornoid lamella: oblique parakeratotic columns over vacuolated keratinocytes with absent granular layer. Histology shows sparse dermal lymphocytic infiltrate, epidermal thinning beneath lamella. Clinicopathologic correlation is paramount, as early papules may lack classic features. Dermoscopy highlights ridged borders with thread-like vessels. Genetic testing for chromosome 12q loci is investigational.
- Key Diagnostic Criteria:
- Onset in adolescence on palms/soles
- Disseminated annular lesions with hyperkeratotic rims
- Biopsy-proven cornoid lamella
- Family history (if familial)
Differential diagnoses
PPPD mimics other palmoplantar keratodermas and porokeratoses:
- Punctate palmoplantar keratoderma type 1: Seed-like keratoses without cornoid lamella or dissemination
- Arokeratoelidoosis of Costa: Elastotic papules on hands, no body spread
- Disseminated superficial actinic porokeratosis (DSAP): Sun-exposed only, no palmoplantar emphasis
- Porokeratosis of Mibelli: Fewer, larger plaques
- Linear porokeratosis: Blaschko-linear distribution
- Hyperkeratosis-hyperpigmentation syndrome: Pigmented keratoses without annularity
Treatment
No curative therapy exists; management is symptomatic and suppressive.
- Topical therapies: Retinoids (tazarotene), keratolytics (urea, salicylic acid), calcipotriol reduce hyperkeratosis; variable efficacy
- Systemic retinoids: Acitretin or isotretinoin (0.5-1 mg/kg/day) induces remission in 50-70%, but relapse post-discontinuation common; monitor lipids/hepatic function
- Phototherapy: PUVA or UVB effective for disseminated lesions, though paradoxical worsening reported
- Other: Cryotherapy, laser ablation (CO2/Erbium:YAG), 5-FU for localized sites; surgical excision for malignancy
- Emerging: Ingenol mebutate, imiquimod; limited data
Multimodal approaches optimize control; maintenance therapy mitigates relapse.
Outcome
PPPD follows a chronic, relapsing course, fluctuating with seasons and worsening in summer. Response to retinoids is favorable short-term, but lifelong monitoring for SCC is essential, with biopsies of suspicious lesions. Quality of life improves with aggressive management, though complete clearance is rare. Prognosis is good absent malignancy.
Frequently Asked Questions (FAQs)
Q: Is PPPD contagious?
A: No, PPPD is a genetic keratinization disorder, not infectious.
Q: Does PPPD always run in families?
A: Most cases are autosomal dominant familial, but sporadic mutations occur.
Q: Can PPPD turn into skin cancer?
A: Yes, rare risk of squamous cell carcinoma in longstanding lesions; regular check-ups advised.
Q: What is the best treatment for PPPD?
A: Oral retinoids like acitretin offer best response, though relapse common; topicals for mild cases.
Q: Why do PPPD lesions worsen in summer?
A: UV exposure triggers keratinocyte proliferation in genetically susceptible skin.
References
- Porokeratosis plantaris, palmaris, et disseminata — Jih MH et al. eScholarship. 2003. https://escholarship.org/uc/item/5p52z5xk
- Porokeratosis plantaris palmaris et disseminata — Orphanet. 2020-08. https://www.orpha.net/en/disease/detail/737
- Porokeratosis plantaris, palmaris et disseminata — DermNet NZ. Accessed 2026. https://dermnetnz.org/topics/porokeratosis-plantaris-palmaris-et-disseminata
- Porokeratosis: An enigma beginning to unravel — Das A et al. Indian J Dermatol Venereol Leprol. 2022. https://ijdvl.com/porokeratosis-an-enigma-beginning-to-unravel/
- Porokeratoses—A Rare Group of Dermatoses — Anderska A et al. PMC. 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC11596848/
- Porokeratosis: A Review of its Pathophysiology, Clinical… — Actas Dermo. Accessed 2026. http://www.actasdermo.org/en-porokeratosis-a-review-its-pathophysiology-articulo-S1578219020302055
Read full bio of Sneha Tete














